Related Experiment Video

Updated: May 3, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.4K

Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia

C D Garlichs1, S John, A Schmeisser

  • 1Medical Clinic II and Medical Clinic IV, Friedrich Alexander University, Erlangen-Nürnberg, Germany. Christoph.Garlichs@rzmail.uni-erlangen.de

Circulation
|November 14, 2001
PubMed

Insights

Hypercholesterolemia elevates the CD40 system, increasing inflammation and clotting risk. Statin therapy effectively reduces CD40 and related inflammatory markers in patients.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Hypercholesterolemia is a significant risk factor for cardiovascular disease, linked to inflammation and hypercoagulability.
  • The CD40 system plays a role in mediating these inflammatory and hypercoagulable states.
  • This study examines the CD40 system's role in moderate hypercholesterolemia and its response to statin therapy.

Purpose of the Study:

  • To investigate the upregulation of the CD40 system in patients with moderate hypercholesterolemia.
  • To determine the influence of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor therapy on the CD40 system.
  • To explore the relationship between cholesterol levels, CD40 pathway components, and inflammatory markers.

Main Methods:

  • Compared CD154 and P-selectin on platelets, and CD40 on monocytes between 15 hypercholesterolemic patients and 15 healthy controls.
  • Analyzed soluble CD154 and monocyte chemoattractant protein-1 (MCP-1) blood concentrations.
  • Utilized double-label flow cytometry and in vitro platelet-endothelial cell coculture models.

Main Results:

  • Hypercholesterolemic patients exhibited significantly increased CD154 and P-selectin on platelets and CD40 on monocytes compared to controls.
  • Elevated C-reactive protein in patients upregulated CD40 on monocytes in vitro.
  • Platelet CD154 enhanced MCP-1 release, which was elevated in patients and in vitro models.
  • HMG-CoA reductase inhibitor therapy significantly reduced CD40 on monocytes and serum MCP-1 levels.

Conclusions:

  • The CD40 system is upregulated in moderate hypercholesterolemia, potentially contributing to a proinflammatory, proatherogenic, and prothrombotic state.
  • Statin therapy demonstrates a beneficial effect by downregulating key components of the CD40 system and reducing MCP-1.
  • Targeting the CD40 pathway may offer therapeutic strategies for managing cardiovascular risks associated with hypercholesterolemia.
Abstract

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
105.4K
Inflammation01:38

Inflammation

Overview
46.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741